Dashboard
Manage Tickers

RNXTRenovoRx, Inc.

Nasdaq www.renovorx.com


$ 1.37 $ 0.10 (7.81 %)    

Friday, 10-May-2024 12:28:17 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 441.71 $ -1.21 (-0.27 %)
DIA $ 395.04 $ 1.04 (0.26 %)
SPY $ 520.76 $ 0.59 (0.11 %)
TLT $ 90.14 $ -0.49 (-0.54 %)
GLD $ 218.73 $ 1.78 (0.82 %)
$ 1.45
$ 1.33
$ 0.00 x 0
$ 1.42 x 100
$ 1.33 - $ 1.37
$ 0.53 - $ 3.29
23,412
na
14.92M
$ 1.45
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-01-2024 12-31-2023 10-K
2 11-13-2023 09-30-2023 10-Q
3 08-16-2023 06-30-2023 10-Q
4 05-12-2023 03-31-2023 10-Q
5 03-31-2023 12-31-2022 10-K
6 11-14-2022 09-30-2022 10-Q
7 08-12-2022 06-30-2022 10-Q
8 05-13-2022 03-31-2022 10-Q
9 03-30-2022 12-31-2021 10-K
10 11-15-2021 09-30-2021 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

renovorx-regains-nasdaq-compliance
RenovoRx Regains Nasdaq Compliance
04/18/2024 12:35:08

renovorx-executes-definitive-subscription-agreement-with-accredited-investors-for-111m-at-market-private-placement
RenovoRx Executes Definitive Subscription ...
04/08/2024 12:36:43

Cash position now expected to fund current operating plan into 2026Financing provides cash runway to advance the ongoing pivota...

alliance-global-partners-initiates-coverage-on-renovorx-with-buy-rating-announces-price-target-of-4
Alliance Global Partners Initiates Coverag...
02/02/2024 13:04:15

Alliance Global Partners analyst Scott Henry initiates coverage on RenovoRx (NASDAQ:RNXT) with a Buy rating and announces Pr...

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/31/2024 17:31:12

12-health-care-stocks-moving-in-wednesdays-intraday-session
12 Health Care Stocks Moving In Wednesday'...
01/10/2024 17:31:03

why-longboard-pharmaceuticals-shares-are-trading-higher-by-around-200-here-are-other-stocks-moving-in-tuesdays-mid-day-session
Why Longboard Pharmaceuticals Shares Are T...
01/02/2024 18:35:24

Shares of Longboard Pharmaceuticals, Inc.

12-health-care-stocks-moving-in-tuesdays-intraday-session
12 Health Care Stocks Moving In Tuesday's ...
01/02/2024 17:31:04

12-health-care-stocks-moving-in-mondays-intraday-session
12 Health Care Stocks Moving In Monday's I...
01/01/2024 17:30:55

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
12/29/2023 17:31:07

why-douyu-international-shares-are-trading-higher-by-14-here-are-other-stocks-moving-in-thursdays-mid-day-session
Why DouYu International Shares Are Trading...
12/28/2023 18:07:18

Shares of DouYu International Holdings Limited (NASDAQ: DOYU) rose sharply during Thursday’s session after announcing a share ...

renovorx-engages-oklahoma-university-health-as-first-clinical-site-in-preparation-for-the-pivotal-phase-iii-cougar-clinical-trial-in-bile-duct-cancer
RenovoRx Engages Oklahoma University Healt...
12/21/2023 13:33:24

This study will be the Second Clinical Trial Evaluating RenovoGem™, a Combination Drug-Device Product, in a Difficult-to-Access...

renovorx-announced-acceptance-of-clinical-data-abstract-for-the-2024-society-of-interventional-radiology-annual-scientific-meeting
RenovoRX Announced Acceptance Of Clinical ...
12/19/2023 13:41:49

Research Supports RenovoRx's Lead Oncology Product Candidate, RenovoGem™, and its Novel Therapy Platform, TAMP™, for the Tr...

12-health-care-stocks-moving-in-fridays-pre-market-session
12 Health Care Stocks Moving In Friday's P...
12/15/2023 13:08:05

12-health-care-stocks-moving-in-thursdays-after-market-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 21:31:15

12-health-care-stocks-moving-in-thursdays-intraday-session
12 Health Care Stocks Moving In Thursday's...
12/14/2023 17:32:05

renovorx-files-new-international-patent-for-novel-targeted-combination-drug-delivery-oncology-therapy-platform-expands-ip-coverage-for-tamp-to-deliver-therapeutic-classes-across-dnarna-altering-modalities-cell-therapy-and-antibody-based-therapies
RenovoRx Files New International Patent Fo...
12/13/2023 13:34:21

RenovoRx Holds a Strong Intellectual Property (IP) Portfolio with 9 Issued Patents for its Proprietary Trans-Arterial Micro-Per...

maxim-group-downgrades-renovorx-to-hold
Maxim Group Downgrades RenovoRx to Hold
11/15/2023 16:29:07

Maxim Group analyst Jason McCarthy downgrades RenovoRx (NASDAQ:RNXT) from Buy to Hold.

recap-renovorx-q3-earnings
Recap: RenovoRx Q3 Earnings
11/14/2023 14:30:18

renovorx-q3-eps-013-beats-030-estimate
RenovoRx Q3 EPS $(0.13) Beats $(0.30) Esti...
11/14/2023 13:35:58

RenovoRx (NASDAQ:RNXT) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.30) by 5...

roth-mkm-maintains-buy-on-renovorx-lowers-price-target-to-13
Roth MKM Maintains Buy on RenovoRx, Lowers...
08/18/2023 14:35:58

Roth MKM analyst Scott Henry maintains RenovoRx (NASDAQ:RNXT) with a Buy and lowers the price target from $14 to $13.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION